Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-028418

Ocera Therapeutics, Inc. · OCRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Byrnes
Officer — CFO and Treasurer
Period of report
Dec 11, 2017
Accepted (ET)
Dec 11, 2017 · 3:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Dec 11, 2017D13,000$1.52D0D
Common StockF1,F2,F3Dec 11, 2017D150,000$1.52D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F4,F5,F6$2.98Dec 11, 2017D123,300D—Jan 5, 2026Common Stock123,3000D
Stock Option (Right to Buy)F4,F5,F7$7.50Dec 11, 2017D55,000D—Jul 1, 2024Common Stock55,0000D
Stock Option (Right to Buy)F4,F5,F8$3.76Dec 11, 2017D75,000D—Jun 17, 2025Common Stock75,0000D
Stock Option (Right to Buy)F4,F5,F9$2.15Dec 11, 2017D102,300D—Dec 14, 2026Common Stock102,3000D
Stock Option (Right to Buy)F4,F5,F10$7.50Dec 11, 2017D70,000D—Dec 2, 2024Common Stock70,0000D

Explanation of responses